Minerva Neurosciences Inc reports results for the quarter ended in September 30 - Earnings Summary

Minerva Neurosciences

06/11/2024 04:59

* Minerva Neurosciences Inc  NERV.OQ  reported a quarterly
adjusted loss of 54 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of $-1.03.  The lone analyst forecast for
the quarter was for a loss of $1.01 per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * Minerva Neurosciences Inc's reported EPS for the quarter
was
$2.97​.
    * The company reported quarterly net income of $22.51
million.
    * Minerva Neurosciences Inc shares had fallen by 13.1% this
quarter and lost 62.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Minerva
Neurosciences Inc is $5.00 
This summary was machine generated from LSEG data November 6 at
04:59 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -1.01          -0.54          Beat
 Jun. 30 2024      -0.97          -1.09          Missed
 Mar. 31 2024      -1.20          -1.13          Beat
 Dec. 31 2023      -0.88          -1.39          Missed